“An awesome responsibility”: A conversation with CIRM board member Kim Barrett

Written by Holly Alyssa MacCormick It’s not every day that you get to contribute to something that could help save a life, but when Kim Barrett joined the board of the California Institute for Regenerative Medicine (CIRM), that’s exactly what happened. Barrett is a research physiologist. For 36 years she studied the cells of the … Continue reading “An awesome responsibility”: A conversation with CIRM board member Kim Barrett

CIRM Welcomes New Board Members 

The California Institute for Regenerative Medicine (CIRM) is thrilled to welcome a distinguished group of new board members and alternates, each bringing a wealth of experience and leadership in healthcare, research, and innovation.   Joyce A. Sackey, MD, FACP Dr. Sackey joins CIRM as an alternate for Linda Boxer. As the inaugural Chief Equity, Diversity, and … Continue reading CIRM Welcomes New Board Members 

CIRM Recommendations from Strategic Allocation Framework

The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutes dedicated to regenerative medicine, announced key recommendations at the September 26, 2024, Independent Citizens’ Oversight Committee Meeting from its Strategic Allocation Framework (SAF), a structured and data-driven effort designed to prioritize resources and maximize the impact of CIRM’s funding. These recommendations mark … Continue reading CIRM Recommendations from Strategic Allocation Framework

CIRM Board Approves Continued Funding for SPARK and Alpha Stem Cell Clinics

Yesterday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved $8.5 million to continue funding of the Summer Program to Accelerate Regenerative Medicine Knowledge (SPARK) and Alpha Stem Cell Clinics (ASCC). This past February, the Board approved continued funding for stem cell focused educational programs geared towards undergraduate, masters, pre/postdoctoral, and medical … Continue reading CIRM Board Approves Continued Funding for SPARK and Alpha Stem Cell Clinics